Skip to main content

Table 3 Checklist for intervention co-creation adapted from Leask et al., 2019 [38]

From: OPTImising the implementation of pulMonary rehAbiLitation in people with chronic obstructive pulmonary disease (the OPTIMAL study): mixed methods study protocol

Section

Checklist item

Planning

 How was the aim of the study framed?

1. Use each element of the PRODUCES framework (Problem, Objective, Design, (end)-Users, Co-creators, Evaluation, Scalability).

 Explain the sampling procedure

2. Explain the criteria used for sampling.

3. In what setting did the sampling occur?

4. How many individuals engage as co-creators? (Academic / non-academic stakeholders?) .

5. Describe the co-creators (demographics / groups / other characteristics of interest).

Conducting

 How was ownership manifested?

6) Explain the methods used to manifest ownership among the co-creators.

 Procedure components

7) What level of participation was there from the co-creators?

8) How was the overall aim presented?

9) How was the purpose of each meeting presented?

10) What were the rules and responsibilities of participation agreed upon?

 Procedure methods

11) In which areas did the co-creators require upskilling?

12) What previous evidence was reviewed, and how?

12) If a prototype was developed, describe the prototype and the prototyping process.

14) Describe the frequency and duration of meetings.

15) Give examples of interactive techniques or methods used.

16) Give examples of fieldwork techniques or methods used.

17) Give examples of how iteration occurred during the process.

Evaluation

 Process

18) Explain how co-creators satisfaction and contribution was evaluated (e.g. reporting attendance rates, feedback questionnaires, interviews, etc.).

19) How are results reported back to stakeholders and the public?

 Outcome

20) Explain how the validity of the outcome and process were evaluated (e.g. face validation, member checking, etc.).

22) Explain plans for formal testing of the effectiveness/scalability of the co-created outcome.

21) Explain outcome of the evaluation (if tested).